Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicenter Prospective Observational Study to Derive and Verify the Performance of a Host-response Based Diagnostic Tool for Early Detection of Severe Infections.

NCT06665542 is registered in ClinicalTrials.gov with MeMed Diagnostics Ltd. as lead sponsor.

NCT NCT06665542
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06665542 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicenter Prospective Observational Study to Derive and Verify the Performance of a Host-response Based Diagnostic Tool for Early Detection of Severe Infections.
Lead sponsor
MeMed Diagnostics Ltd.
Phase
Observational
Overall status
Active, not recruiting
Start date
November 12, 2020
Completion date
December 31, 2025
Enrollment
2,000 (estimated)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

acute infection, sepsis